...
首页> 外文期刊>American Journal of Physiology >Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity
【24h】

Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity

机译:II型Bartter综合征的小鼠模型。 I.噻嗪类敏感的Na-Cl共转运活性上调

获取原文
获取原文并翻译 | 示例

摘要

Nevertheless, the high survival rate of our inbred Romk mice suggests that specific genes have been selected which could have mitigated fluid and electrolyte losses. Consequently, the selected adaptive changes in the Romk mouse could have altered the mouse phenotype compared with that observed in HPS. Diuretic pharmacotyping has been used to separate the various phenotypes of hypokalemic renal salt-wasting disorders (22) and can be used to compare responses in Romkr mice and type II HPS. The differential sensitivities to diuretics has established that the defect in HPS was localized to the TAL (25). Thus individuals with HPS exhibit impaired diuretic and natriuretic responses to furosemide, while the effect of this diuretic in Gitelman's disorder is normal (22). In contrast, individuals with Gitelman's disorder exhibit a markedly reduced response to thiazide diuretics that inhibit the thiazide-sensitive NaCl cotransporter localized in the distal convoluted-tubule (DCT), while the response to this diuretic is exaggerated in HPS.
机译:尽管如此,我们近交Romk小鼠的高存活率表明已经选择了可以减轻体液和电解质损失的特定基因。因此,与在HPS中观察到的相比,在Romk小鼠中选择的适应性改变可能已经改变了小鼠的表型。利尿药效法已被用于分离低钾肾功能衰竭的各种表型(22),并可用于比较Romkr小鼠和II型HPS的反应。对利尿药的敏感性不同,已经确定HPS的缺陷局限于TAL(25)。因此,患有HPS的个体对呋塞米的利尿和利尿钠反应减弱,而这种利尿剂在吉特曼氏病中的作用却是正常的(22)。相比之下,患有吉特曼氏病的人对噻嗪利尿剂的反应明显降低,从而抑制了位于远端回旋管(DCT)中的噻嗪敏感性NaCl协同转运蛋白,而在HPS中这种利尿剂的反应被夸大了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号